{"id":"https://openalex.org/W3211979601","doi":"https://doi.org/10.1182/blood-2021-151982","title":"Targeting Venetoclax-Resistant CLL By Bcl-XL Degradation","display_name":"Targeting Venetoclax-Resistant CLL By Bcl-XL Degradation","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3211979601","doi":"https://doi.org/10.1182/blood-2021-151982","mag":"3211979601"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-151982","doi":"https://doi.org/10.1182/blood-2021-151982","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-151982","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062306420","display_name":"Daisy Diaz Rohena","orcid":"https://orcid.org/0000-0001-6286-4910","observed_orcids":["https://orcid.org/0000-0001-6286-4910"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daisy Diaz Rohena","raw_affiliation_strings":["Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040448271","display_name":"Janani Ravikrishnan","orcid":"https://orcid.org/0000-0003-0933-3883","observed_orcids":["https://orcid.org/0000-0003-0933-3883"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Janani Ravikrishnan","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103241521","display_name":"Chaomei Liu","orcid":"https://orcid.org/0000-0003-1449-4286","observed_orcids":["https://orcid.org/0000-0003-1449-4286"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chaomei Liu","raw_affiliation_strings":["Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058794772","display_name":"Guangrong Zheng","orcid":"https://orcid.org/0000-0002-8106-6663","observed_orcids":["https://orcid.org/0000-0002-8106-6663"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guangrong Zheng","raw_affiliation_strings":["Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100781093","display_name":"Daohong Zhou","orcid":"https://orcid.org/0000-0002-2400-6461","observed_orcids":["https://orcid.org/0000-0002-2400-6461","https://orcid.org/0000-0002-7771-6299"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daohong Zhou","raw_affiliation_strings":["Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacodynamics, College of Pharmacy, University of Florida, Gainesville, FL","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103143851","display_name":"Peiyi Zhang","orcid":"https://orcid.org/0000-0003-0207-1112","observed_orcids":["https://orcid.org/0000-0003-0207-1112"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peiyi Zhang","raw_affiliation_strings":["Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, FL","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G. Wierda","raw_affiliation_strings":["Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021380291","display_name":"Nitin Jain","orcid":"https://orcid.org/0000-0003-0114-8384","observed_orcids":["https://orcid.org/0000-0003-0114-8384"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nitin Jain","raw_affiliation_strings":["Department of Leukemia, MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Leukemia, MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014241029","display_name":"Jennifer Ann Woyach","orcid":"https://orcid.org/0000-0002-3403-9144","observed_orcids":["https://orcid.org/0000-0002-3403-9144"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer A. Woyach","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046657449","display_name":"Deepa Sampath","orcid":"https://orcid.org/0000-0002-4366-8436","observed_orcids":["https://orcid.org/0000-0002-4366-8436"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deepa Sampath","raw_affiliation_strings":["Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"2252","last_page":"2252"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9369999766349792},{"id":"https://openalex.org/keywords/venetoclax-resistance","display_name":"venetoclax resistance","score":0.9929999709129333},{"id":"https://openalex.org/keywords/protac-degraders","display_name":"PROTAC degraders","score":0.9869999885559082},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.5740000009536743},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5960000157356262},{"id":"https://openalex.org/keywords/primary-cll-cells","display_name":"primary CLL cells","score":0.5659999847412109},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.5740000009536743},{"id":"https://openalex.org/keywords/bcl-2-family-proteins","display_name":"Bcl-2 family proteins","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.9945793151855469},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7010265588760376},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6275691986083984},{"id":"https://openalex.org/C2776789625","wikidata":"https://www.wikidata.org/wiki/Q4875408","display_name":"Bcl-xL","level":4,"score":0.6146553754806519},{"id":"https://openalex.org/C2780790343","wikidata":"https://www.wikidata.org/wiki/Q5090610","display_name":"Chemoimmunotherapy","level":4,"score":0.5376604199409485},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.518207848072052},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4367801547050476},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4138905107975006},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33969563245773315},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.337119996547699},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3262140154838562},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.26520219445228577},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2153109610080719},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11022558808326721}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2021-151982","doi":"https://doi.org/10.1182/blood-2021-151982","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-151982","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310093212","https://openalex.org/W4405092582","https://openalex.org/W3211585757","https://openalex.org/W4401420326","https://openalex.org/W2989163710","https://openalex.org/W2951974395","https://openalex.org/W2791038413","https://openalex.org/W2620804057","https://openalex.org/W4389259461","https://openalex.org/W6997024090"],"abstract_inverted_index":{"Abstract":[0],"Chronic":[1],"lymphocytic":[2],"leukemia":[3,9],"(CLL)":[4],"is":[5,13,105,133,145,225,352,453],"the":[6,25,37,122,126,175,221,246,288,321,426,432,435,456,569,648],"most":[7],"prevalent":[8],"in":[10,57,83,95,107,168,174,181,199,267,363,471,507,524,550,605,617,643,674,689,704],"adults":[11],"and":[12,91,114,191,258,307,335,341,391,479,522,575,627,667,682,697],"associated":[14,226,458],"with":[15,24,110,227,253,274,425,459],"resistance":[16,76,461,633,657],"to":[17,42,86,125,140,165,172,193,220,232,235,285,378,413,563,601,619,634,645,655,658],"apoptosis.":[18,635],"Clinical":[19],"responses":[20,600],"are":[21],"dramatically":[22],"improved":[23],"use":[26],"of":[27,36,60,74,121,129,177,332,374,434,455,492,650,670,685,700,851],"targeted":[28,424],"therapies":[29],"such":[30,624],"as":[31,119,346,504,506,596,625,629],"venetoclax,":[32],"a":[33,64,134,291,372,410,606,615,630,847],"selective":[34],"inhibitor":[35],"anti-apoptotic":[38],"protein":[39,196,392],"Bcl-2,":[40,445],"compared":[41,284,377],"chemoimmunotherapy.":[43],"However,":[44,610],"some":[45],"patients":[46,109,219,273,474,589],"can":[47,422],"ultimately":[48],"develop":[49],"resistant":[50,637],"CLL.":[51,170],"Bcl-xL":[52,118,132,158,167,222,257,357,400,407,428,521,542,626,653,671,686,701],"overexpression":[53,408],"has":[54,152],"been":[55,154],"implicated":[56],"multiple":[58,200],"mechanisms":[59],"venetoclax":[61,75,104,460],"resistance,":[62],"representing":[63],"switch":[65],"that":[66,211,399,406,418,584],"confers":[67,409],"cell":[68,403,555],"survival":[69,84,411],"despite":[70],"Bcl-2":[71,79,259,494,511,523,531,538,554,567,593,621,659],"inhibition.":[72],"Mechanisms":[73],"include":[77],"mutated":[78],"(ex.":[80],"G101V),":[81],"switches":[82],"dependence":[85,618],"alternative":[87,620],"BCL2":[88],"family":[89,622],"members,":[90],"microenvironmental":[92],"interactions":[93],"(Reviewed":[94],"Bose":[96],"et":[97,205,476,482,486],"al.,":[98,206,477,483,487],"2017).":[99],"Moreover,":[100],"disease":[101],"progression":[102],"on":[103,592],"accelerated":[106],"CLL":[108,139,214,275,414,420,585,612,638],"aberrant":[111],"p53":[112],",":[113],"our":[115],"laboratory":[116],"identified":[117,470],"one":[120,454],"main":[123],"contributors":[124],"oncogenic":[127],"abilities":[128],"mutant":[130,450,553,566],"p53.Thus,":[131],"promising":[135],"target":[136,166,194],"for":[137,147,197,303,312,381,594,632],"re-sensitizing":[138],"apoptosis,":[141],"but":[142,539],"since":[143],"it":[144,468,534],"crucial":[146],"platelet":[148],"viability,":[149],"direct":[150],"targeting":[151],"not":[153,536],"clinically":[155],"successful.":[156],"New":[157],"PROTAC":[159],"degraders":[160,187,289,436],"provide":[161],"an":[162,640,748,889],"exciting":[163],"opportunity":[164],"venetoclax-resistant":[169,419,473,611],"Due":[171],"differences":[173],"expression":[176],"VHL":[178],"E3":[179],"ligase":[180],"cancer":[182],"cells":[183,269,366,421,440,496,509,527,586,613],"versus":[184],"platelets,":[185],"these":[186,317,651],"have":[188],"shown":[189],"potency":[190,255,266,433],"selectivity":[192],"this":[195,675,690,705],"degradation":[198,362,393,401,543],"Bcl-xL-dependent":[201],"malignancies":[202],"(He,":[203],"Y.":[204],"2020).":[207],"Our":[208,262],"results":[209,263],"show":[210,561],"exposing":[212],"primary":[213,268],"samples":[215],"(n=4)":[216],"from":[217,270,465,587],"treatment-na\u00efve":[218],"degrader":[223,249],"DT2216":[224,559],"apoptosis":[228,319,387,491],"at":[229,241,280,295,355,367,371,547,568,578],"concentrations":[230,297,571],"known":[231],"be":[233,423],"non-toxic":[234],"platelets":[236],"(EC50":[237,276,500,514],"=":[238,277,300,309,501,515],"162":[239],"nM":[240,279,314,380],"18":[242,281],"hr":[243,282,302,311,369],"treatment).":[244],"Furthermore,":[245],"dual":[247],"Bcl-xL/Bcl-2":[248],"PZ18753B":[250,351,489,518],"was":[251,324,469],"synthesized":[252],"enhanced":[254,265],"against":[256,437],"co-dependent":[260],"cancers.":[261],"confirm":[264],"treatment":[271,370],"na\u00efve":[272],"7.602":[278],"treatment),":[283],"DT2216.":[286,382],"Also,":[287],"exhibit":[290],"similar":[292],"kinetic":[293],"profile":[294],"10-fold":[296],"(n=5,":[298],"t1/2":[299,308],"2.3":[301],"1":[304,548,579],"uM":[305,549],"DT2216,":[306,359],"3.1":[310],"100":[313],"PZ18753B).":[315],"For":[316],"results,":[318],"via":[320],"mitochondrial":[322,336],"pathway":[323],"studied":[325,431],"by":[326,338,348,388,394,598],"flow":[327],"cytometry,":[328],"assessing":[329],"extracellular":[330],"exposure":[331],"phosphatidyl":[333],"serine":[334],"depolarization":[337],"Annexin":[339],"V":[340],"TMRM":[342],"staining,":[343],"respectively.":[344],"Consistently,":[345],"confirmed":[347,398],"Western":[349,395],"Blot,":[350,396],"more":[353],"potent":[354,541,652],"degrading":[356],"than":[358],"achieving":[360],"50%":[361],"RS4;11":[364,438,493,508,525,530],"leukemic":[365,439],"46":[368,498],"concentration":[373],"0.86":[375],"nM,":[376],"7.83":[379],"Comparing":[383],"dose-response":[384],"curves":[385],"showing":[386],"AnnexinV/TMRM":[389],"staining":[390],"we":[397,416],"precedes":[402],"death.":[404],"Given":[405],"advantage":[412],"cells,":[415,533],"hypothesize":[417],"new":[427],"degraders.":[429],"We":[430,581],"which":[441,644],"express":[442],"wildtype":[443],"(WT)":[444],"or":[446],"also":[447,582],"overexpress":[448],"G101V":[449,512,532,565],"Bcl-2.":[451],"This":[452],"mutations":[457],"and,":[462],"combining":[463],"data":[464],"various":[466],"cohorts,":[467],"23%":[472],"(Blombery":[475],"2019":[478],"2020;":[480],"Tausch":[481],"2019;":[484],"Weiss":[485],"2019).":[488],"induced":[490],"WT":[495,526,551],"within":[497],"hrs":[499],"11.1":[502],"nM)":[503],"well":[505],"expressing":[510],"mutation":[513],"109.1":[516],"nM).":[517],"degraded":[519],"both":[520],"effectively.":[528],"In":[529],"did":[535,560],"affect":[537],"retained":[540],"(86%":[544],"vs":[545,552],"75%":[546],"lines,":[556],"respectively).":[557],"Interestingly,":[558],"ability":[562],"degrade":[564],"highest":[570],"tested":[572],"(Ex.":[573],"36%":[574],"33%,":[576],"respectively,":[577],"uM).":[580],"demonstrated":[583],"chemo-na\u00efve":[588],"depend":[590],"primarily":[591],"survival,":[595],"measured":[597],"their":[599],"BH3":[602,607],"mimetic":[603],"peptides":[604],"profiling":[608],"assay.":[609],"undergo":[614],"shift":[616],"proteins,":[623],"Mcl-1,":[628],"mechanism":[631],"Thus,":[636],"represents":[639],"excellent":[641],"setting":[642],"continue":[646],"testing":[647],"efficacy":[649],"degraders,":[654],"overcome":[656],"inhibitors.":[660],"Disclosures":[661],"Zheng:":[662],"Dialectic":[663,678,693],"Therapeutics:":[664,679,694,717,808,812,820,830],"Other:":[665,680,695,867,873],"Co-founder":[666,681,696],"stakeholder.":[668,683,698],"Inventor":[669,684],"PROTACS":[672,687],"disclosed":[673,688,703],"study..":[676,691,706],"Zhou:":[677],"Zhang:":[692],"Co-inventor":[699],"PROTACs":[702],"Wierda:":[707],"Oncternal":[708],"Therapeutics,":[709],"Inc.:":[710,738,743],"Research":[711,714,718,721,725,728,731,734,739,744,751,755,758,761,764,767,773,777,781,786,792,796,802,805,809,813,817,822,827,836,839,856],"Funding;":[712,715,719,722,726,729,732,735,740,745,752,756,759,762,765,768,778,782,787,793,797,803,806,810,814,818,823,828,837,857],"Genentech:":[713,815],"Juno":[716],"Xencor:":[720],"KITE":[723],"Pharma:":[724],"Sunesis:":[727],"GSK/Novartis:":[730],"Janssen:":[733,832],"Loxo":[736,844],"Oncology,":[737],"Acerta":[741],"Pharma":[742],"Pharmacyclics":[746,887],"LLC,":[747,888],"AbbVie":[749,842,858,877,890],"Company:":[750,855],"Gilead":[753,870],"Sciences:":[754],"Karyopharm:":[757],"Miragen:":[760],"Cyclacel:":[763],"AstraZeneca:":[766,794],"Genzyme":[769],"Corporation:":[770],"Consultancy;":[771],"AbbVie:":[772,834],"Funding.":[774,840],"Jain:":[775],"Incyte:":[776],"Servier:":[779],"Honoraria,":[780,785,791,795,801,816,821,826,835],"Precision":[783],"Biosciences:":[784],"Bristol":[788],"Myers":[789],"Squibb:":[790],"Beigene:":[798,866],"Honoraria;":[799,831,833],"Cellectis:":[800],"Pfizer:":[804],"Fate":[807],"Aprea":[811],"ADC":[819],"Adaptive":[824],"Biotechnologies:":[825],"TG":[829],"Pharmacyclics:":[838],"Woyach:":[841],"Inc,":[843,846,859,861,864,878,880,886],"Oncology":[845],"wholly":[848],"owned":[849],"subsidiary":[850],"Eli":[852],"Lilly":[853],"&":[854,875],"ArQule":[860,879],"Janssen":[862,884],"Biotech":[863,885],"AstraZeneca,":[865],"Advisory":[868],"Committee;":[869],"Sciences":[871],"Inc:":[872],"Data":[874],"Safety;":[876],"AstraZeneca":[881],"Pharmaceuticals":[882],"LP,":[883],"Company,:":[891],"Consultancy.":[892]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-11-22T00:00:00"}